SAMSRITA LABS LIMITED (SAMSRITA.BO)
INR 15.58
(4.99%)
INR 15.58
(4.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.28 Million INR | 0.67% |
| 2022 | -1.29 Million INR | 48.08% |
| 2021 | -2.48 Million INR | 56.84% |
| 2020 | -5.76 Million INR | 29.77% |
| 2019 | -8.2 Million INR | -77.4% |
| 2018 | -4.62 Million INR | -125.96% |
| 2017 | -2.04 Million INR | 2.01% |
| 2016 | -2.08 Million INR | -286.34% |
| 2015 | 1.12 Million INR | 44.33% |
| 2014 | 777.03 Thousand INR | 0.0% |
| 2013 | - INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - INR | 100.0% |
| 2023 Q4 | -12 Thousand INR | -140.0% |
| 2023 Q1 | -5000.00 INR | 98.83% |
| 2023 Q2 | -5000.00 INR | 0.0% |
| 2023 Q3 | -5000.00 INR | 0.0% |
| 2023 FY | -1.28 Million INR | 0.67% |
| 2022 Q1 | -8000.00 INR | 99.56% |
| 2022 Q4 | -426 Thousand INR | -5225.0% |
| 2022 Q2 | -8000.00 INR | 0.0% |
| 2022 FY | -1.29 Million INR | 48.08% |
| 2022 Q3 | -8000.00 INR | 0.0% |
| 2021 Q1 | -13 Thousand INR | 0.0% |
| 2021 FY | -2.48 Million INR | 56.84% |
| 2021 Q4 | -1.82 Million INR | -13930.77% |
| 2021 Q3 | -13 Thousand INR | 0.0% |
| 2021 Q2 | -13 Thousand INR | 0.0% |
| 2020 FY | -5.76 Million INR | 29.77% |
| 2019 FY | -8.2 Million INR | -77.4% |
| 2018 FY | -4.62 Million INR | -125.96% |
| 2017 FY | -2.04 Million INR | 2.01% |
| 2016 FY | -2.08 Million INR | -286.34% |
| 2015 FY | 1.12 Million INR | 44.33% |
| 2014 FY | 777.03 Thousand INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.46 Million INR | 112.265% |
| Biocon Limited | 91.73 Billion INR | 100.001% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | 100.041% |
| Concord Biotech Limited | 6.11 Billion INR | 100.021% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | 100.026% |
| FERMENTA BIOTECH LIMITED | 1.82 Billion INR | 100.07% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | 177.726% |
| Lyka Labs Limited | 145.95 Million INR | 100.879% |
| Panacea Biotec Limited | 1.35 Billion INR | 100.095% |
| Servoteach Industries Limited | - INR | Infinity% |
| SMS Lifesciences India Limited | 329.57 Million INR | 100.389% |
| Supriya Lifescience Limited | 2.65 Billion INR | 100.048% |
| Syngene International Limited | 12.43 Billion INR | 100.01% |
| TAKE Solutions Limited | 183.42 Million INR | 100.7% |
| Titan Biotech Limited | 884.66 Million INR | 100.145% |
| Transgene Biotek Limited | -1.69 Million INR | 24.168% |
| Vanta Bioscience Limited | 7.12 Million INR | 118.021% |